BioCentury
ARTICLE | Financial News

Tarveda raises $38M series C

January 28, 2016 2:24 AM UTC

Tarveda Therapeutics Inc. (Watertown, Mass.) raised $38 million in a series C round led by new investor Novo A/S (Hellerup, Denmark) and founding investor New Enterprise Associates. Existing investors Flagship Ventures, NanoDimension and Eminent Venture Capital also participated.

Also on Wednesday, the company changed its name to Tarveda from Blend Therapeutics Inc. ...